Gentuzumab ozogamicin berfore allogeneic stem cell transplantation in patients with relapsed CD33+ acute myeloid leukemia
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Gemtuzumab ozogamicin (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 22 Jun 2007 New trial record.
- 16 Apr 2007 Biomarkers information updated